Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma

Prostate adenocarcinoma (PRAD) is the most frequent malignancy, and is the second leading cause of death due to cancer in men. Thus, new prognostic biomarkers and drug targets for PRAD are urgently needed. As we know, nuclear receptor Nur77 is important in cancer development and changes in the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiong-Ying, Liu, Jie, Zhang, Xiao-Kun, Yang, Wan-Ting, Tao, Yu-Tian, Chen, Ce, Qian, Ye-He, Tang, Jin-Shan, Yao, Xin-Sheng, Xu, Ying-He, Wang, Jing-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921667/
https://www.ncbi.nlm.nih.gov/pubmed/36770929
http://dx.doi.org/10.3390/molecules28031238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921667/
https://www.ncbi.nlm.nih.gov/pubmed/36770929
http://dx.doi.org/10.3390/molecules28031238

Ejemplares similares